EUVIMEDEUVIMED entdecken
Open Access

A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)–Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities

Edaise M da Silva, Arnaud Da Cruz Paula, Kimberly Dessources, Sushmita Gordhandas, Pier Selenica, Nadeem R Abu-Rustum, Britta Weigelt, Rajmohan Murali

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Edaise M da Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Fallopian Tube Neoplasms, Carcinoma in Situ, Endometrial Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, AstraZeneca, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with high-grade endometrial carcinoma (HG-EC), concurrent isolated serous tubal intraepithelial carcinoma (STIC) or STIC-like lesions (STIC-LLs) in the fallopian tube(s) may be found. We sought to determine whether concurrently diagnosed HG-ECs and STIC-LLs are genetically related. Six HG-ECs, including serous carcinomas (n = 4) and carcinosarcomas with serous epithelial component (n = 2), with cooccurring STIC-LLs were identified and subjected to microdissection, DNA extraction, and panel sequencing targeting 468 cancer-related genes or, if DNA quantities were limited, to Sanger sequencing. WT1 and p53 protein expression was assessed by immunohistochemistry. We found that 3 HG-ECs and concurrent STIC-LLs shared pathogenic mutations, such as TP53 hotspot, NF2, FBXW7, and PIK3CA mutations. Immunohistochemical analysis revealed that the HG-EC of case 5 lacked WT1 expression and had aberrant p53 expression, although the matched STIC-LL displayed diffuse WT1 expression. Of the remaining 3 cases that did not show evidence of genetic relatedness based on the targeted sequencing panel, 1 STIC-LL harbored a clonal TP53 missense mutation, whereas the matched HG-EC had a distinct clonal TP53 hotspot mutation, a clonal FBXW7 hotspot mutation, and ERBB2 amplification. At the protein level, the p53 expression patterns of the HG-ECs and STIC-LLs were concordant in these 3 cases. Here, we demonstrate that cooccurring HG-ECs and STIC-LLs are genetically related in a subset of cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fallopian Tube NeoplasmsCarcinoma in SituEndometrial NeoplasmsCystadenocarcinoma, SerousHumansFemaleMiddle AgedAgedBiomarkers, TumorMutationTumor Suppressor Protein p53Neoplasm GradingAdult

Stichwörter der Autor:innen

carcinosarcomasgenetic relatednesssequencingserous endometrial carcinomaserous tubal intraepithelial carcinoma

Substanzen

Biomarkers, TumorTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Now with i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Obstetrics and Gynecology, University of North Carolina (UNC) Health, Chapel Hill, North Carolina.
  • Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Gynecologic Oncology, Inova Fairfax Hospital, Falls Church, Virginia.
  • Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: weigeltb@mskcc.org.

Förderung

  • NCI NIH HHS
  • AstraZeneca
  • National Institutes of Health National Cancer Institute
  • Breast Cancer Research Foundation
  • Grail
  • National Institutes of Health
  • Cycle for Survival

Zitieren

APA

da Silva, E. M., Da Cruz Paula, A., Dessources, K., Gordhandas, S., Selenica, P., Abu-Rustum, N. R., Weigelt, B., & Murali, R. (2025). A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)–Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100890

Vancouver

da Silva EM, Da Cruz Paula A, Dessources K, Gordhandas S, Selenica P, Abu-Rustum NR, et al. A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)–Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100890

BibTeX
@article{daSilva2025,
  author = {da Silva, Edaise M and Da Cruz Paula, Arnaud and Dessources, Kimberly and Gordhandas, Sushmita and Selenica, Pier and Abu-Rustum, Nadeem R and Weigelt, Britta and Murali, Rajmohan},
  title = {A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)–Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100890}
}
Kostenlos starten →